Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PIGZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TLCD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PHKG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130987 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC153811 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMNL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARSD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAXE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC29A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on